Data dive: 977 patients help pinpoint who benefits most from VSX device
NCT ID NCT05459818
First seen Jan 07, 2026 · Last updated May 21, 2026 · Updated 21 times
Summary
This study looked at information from 977 people who received the GORE VIABAHN device with a special coating to treat blocked leg arteries. Researchers combined data from multiple studies to find out how well the device keeps arteries open and which patient traits lead to the best results. The goal was to better understand who benefits most from this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL VASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rijnstate
Arnhem, Netherlands
Conditions
Explore the condition pages connected to this study.